Literature DB >> 9060799

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis.

T Ikeda1, K Matsuda, H Itoh, G Shirakami, Y Miyamoto, T Yoshimasa, K Nakao, T Ban.   

Abstract

Brain natriuretic peptide (BNP) is a novel cardiac hormone secreted predominantly from the ventricle. We examined the plasma levels of BNP and atrial natriuretic peptide (ANP) in 13 patients with aortic stenosis undergoing corrective surgery. Preoperative plasma BNP and ANP levels correlated highly with preoperative left ventricular end-systolic wall stress (ESS) (r = 0.96, p < 0.0001 and r = 0.95, p < 0.0001, respectively). Moreover, between preoperative and late postoperative states, the difference of the plasma levels of BNP and ANP correlated with the difference of ESS. In two patients with elevated ESS and quite high preoperative plasma BNP (> 1000 pg/ml), rapid decrease of the plasma level after operation was observed. These results suggest that synthesis and secretion of BNP and ANP are stimulated by the increase of left ventricular end-systolic wall stress in patients with aortic stenosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060799     DOI: 10.1016/s0002-8703(97)70225-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

Review 1.  Natriuretic peptides in heart valve disease.

Authors:  S G Ray
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

2.  Relationship between echocardiographic findings and laboratory serum biomarkers in patients with and without low cardiac output.

Authors:  Mohammad Reza Khalilian; Mohammad Reza Sabri; Abdolrasoul Nikyar; Shaghayegh Haghjooy Javanmard
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

3.  Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.

Authors:  M Weber; M Hausen; R Arnold; H Nef; H Moellman; A Berkowitsch; A Elsaesser; R Brandt; V Mitrovic; C Hamm
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

Review 4.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

5.  Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure.

Authors:  Arun Raizada; Suman Bhandari; Muzaiyan Ahmed Khan; Harsh Vardhan Singh; Sherin Thomas; Vikram Sarabhai; Neelima Singh; Naresh Trehan
Journal:  Indian J Clin Biochem       Date:  2007-03

6.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Authors:  I Raymond; B A Groenning; P R Hildebrandt; J C Nilsson; M Baumann; J Trawinski; F Pedersen
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

7.  Non-Dipper Pattern is a Determinant of the Inappropriateness of Left Ventricular Mass in Essential Hypertensive Patients.

Authors:  Bae Keun Kim; Young-Hyo Lim; Hyung Tak Lee; Jae Ung Lee; Kyung Soo Kim; Soon Gil Kim; Jeong Hyun Kim; Heon Kil Lim; Jinho Shin
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

8.  Revised definition of predicted left ventricular mass using ambulatory blood pressure in healthy Korean adults.

Authors:  Bae Keun Kim; Enshi Xu; Bo Youl Choi; Yonggu Lee; Soon Gil Kim; Yukio Yamori; Jinho Shin
Journal:  Clin Hypertens       Date:  2017-04-16

9.  End-systolic wall stress in aortic stenosis: comparing symptomatic and asymptomatic patients.

Authors:  Rasmus Carter-Storch; Jacob Eifer Moller; Nicolaj Lyhne Christensen; Lars Melholt Rasmussen; Redi Pecini; Eva Søndergård; Lars Melgaard Videbæk; Jordi Sanchez Dahl
Journal:  Open Heart       Date:  2019-04-09

Review 10.  Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease.

Authors:  Abhishek Sharma; Vaseem Ahmed; Aakash Garg; Chirag Aggarwal
Journal:  Dis Markers       Date:  2015-07-22       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.